Dr. Swaroopa Yerrabothala, MD | Lebanon ...

Dr. Swaroopa Yerrabothala

Claim this profile

Dartmouth Hitchcock Medical Center

Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Myeloid Leukemia
5 reported clinical trials
10 drugs studied

Area of expertise

1T-Lymphoblastic Leukemia/Lymphoma
Swaroopa Yerrabothala has run 5 trials for T-Lymphoblastic Leukemia/Lymphoma. Some of their research focus areas include:
IDH positive
FLT3 positive
FLT3 negative
2Myeloid Leukemia
Swaroopa Yerrabothala has run 5 trials for Myeloid Leukemia. Some of their research focus areas include:
IDH positive
FLT3 positive
FLT3 negative

Affiliated Hospitals

Image of trial facility.
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Image of trial facility.
Dartmouth-Hitchcock Medical Center

More about Swaroopa Yerrabothala

Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Swaroopa Yerrabothala has experience with
  • Cytarabine
  • Pembrolizumab
  • Daunorubicin Hydrochloride
  • Idarubicin Hydrochloride
  • Azacitidine
  • Venetoclax

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Swaroopa Yerrabothala specialize in?
Is Swaroopa Yerrabothala currently recruiting for clinical trials?
Are there any treatments that Swaroopa Yerrabothala has studied deeply?
What is the best way to schedule an appointment with Swaroopa Yerrabothala?
What is the office address of Swaroopa Yerrabothala?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security